No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: A meta-analysis from 5472 cases and 4727 controls

Journal of the Neurological Sciences

Volumn 308, Issue 1-2, 2011, Pages 110-116

  Xuan, Chao ^a   Zhang, Bei Bei ^b   Li, Ming ^c   Deng, Kai Feng ^b   Yang, Tao ^d   Zhang, Xiang E ^e  

^a NANKAI UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^e FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Allele; Apolipoprotein E; Meta analysis; Multiple sclerosis

Indexed keywords

APOLIPOPROTEIN E4;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTIPLE SCLEROSIS; POPULATION GENETICS; PRIORITY JOURNAL; CASE CONTROL STUDY; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS;

APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIPLE SCLEROSIS;

EID: 80051583859     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.05.040     Document Type: Article

References (63)

1. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N Engl J Med 343 2000 938 952
2. M. Pugliatti, H.F. Harbo, T. Holmoy, M.T. Kampman, K.M. Myhr, and T. Riise Environmental risk factors in multiple sclerosis Acta Neurol Scand Suppl 188 2008 34 40
3. G.C. Ebers Environmental factors and multiple sclerosis Lancet Neurol 7 2008 268 277
4. G.C. Ebers, A.D. Sadovnick, and N.J. Risch A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group Nature 377 1995 150 151
5. S.E. Baranzini, J. Mudge, J.C. van Velkinburgh, P. Khankhanian, I. Khrebtukova, and N.A. Miller Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis Nature 464 2010 1351 1356
6. M.A. Pericak-Vance, J.B. Rimmler, J.L. Haines, M.E. Garcia, J.R. Oksenberg, and L.F. Barcellos Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study Neurogenetics 5 2004 45 48
7. S. Sawcer, M. Maranian, E. Setakis, V. Curwen, E. Akesson, and A. Hensiek A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility Brain 125 2002 1337 1347
8. K. Reunanen, S. Finnila, M. Laaksonen, M.L. Sumelahti, J. Wikstrom, and T. Pastinen Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study J Neuroimmunol 126 2002 134 142
9. S. Schmidt, L.F. Barcellos, K. DeSombre, J.B. Rimmler, R.R. Lincoln, and P. Bucher Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis Am J Hum Genet 70 2002 708 717
10. J. Poirier Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease Trends Neurosci 17 1994 525 530
11. M. Pinholt, J.L. Frederiksen, and M. Christiansen The association between apolipoprotein E and multiple sclerosis Eur J Neurol 13 2006 573 580
12. K.H. Weisgraber, S.C. Rall Jr., and R.W. Mahley Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms J Biol Chem 256 1981 9077 9083
13. J.M. Ordovas, L. Litwack-Klein, P.W. Wilson, M.M. Schaefer, and E.J. Schaefer Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms J Lipid Res 28 1987 371 380
14. I. Kuhlmann, A.M. Minihane, P. Huebbe, A. Nebel, and G. Rimbach Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review Lipids Health Dis 9 2010 8
15. J.E. Eichner, S.T. Dunn, G. Perveen, D.M. Thompson, K.E. Stewart, and B.C. Stroehla Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review Am J Epidemiol 155 2002 487 495
16. R.W. Mahley, and S.C. Rall Jr. Apolipoprotein E: far more than a lipid transport protein Annu Rev Genomics Hum Genet 1 2000 507 537
17. M. Miyata, and J.D. Smith Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides Nat Genet 14 1996 55 61
18. O.H. Kantarci, D.D. Hebrink, S.J. Achenbach, S.J. Pittock, A. Altintas, and J.L. Schaefer-Klein Association of APOE polymorphisms with disease severity in MS is limited to women Neurology 62 2004 811 814
19. J. Chapman, S. Vinokurov, A. Achiron, D.M. Karussis, K. Mitosek-Szewczyk, and M. Birnbaum APOE genotype is a major predictor of long-term progression of disability in MS Neurology 56 2001 312 316
20. P. Hogh, A. Oturai, K. Schreiber, M. Blinkenberg, O.S. Jorgensen, and L. Ryder Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate Mult Scler 6 2000 226 230
21. F. Fazekas, S. Strasser-Fuchs, H. Kollegger, T. Berger, W. Kristoferitsch, and H. Schmidt Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis Neurology 57 2001 853 857
22. S.J. Weatherby, C.L. Mann, A.A. Fryer, R.C. Strange, C.P. Hawkins, and V.L. Stevenson No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis J Neurol Neurosurg Psychiatry 68 2000 532
23. T. Masterman, Z. Zhang, D. Hellgren, H. Salter, M. Anvret, and L. Lilius APOE genotypes and disease severity in multiple sclerosis Mult Scler 8 2002 98 103
24. G. Savettieri, V. Andreoli, S. Bonavita, R. Cittadella, C. Caltagirone, and M.C. Fazio Apolipoprotein E genotype does not influence the progression of multiple sclerosis J Neurol 250 2003 1094 1098
25. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
26. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
27. C. Ballerini, D. Campani, G. Rombola, B. Gran, B. Nacmias, and M.P. Amato Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis Neurosci Lett 296 2000 174 176
28. C. Ferri, F.L. Sciacca, F. Veglia, F. Martinelli, G. Comi, and N. Canal APOE epsilon2-4 and -491 polymorphisms are not associated with MS Neurology 53 1999 888 889
29. M. Niino, S. Kikuchi, T. Fukazawa, I. Yabe, and K. Tashiro Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis Mult Scler 9 2003 382 386
30. S. Al-Shammri, H. Fatania, R. Al-Radwan, and A.O. Akanji The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects Clin Chim Acta 351 2005 203 207
31. E. Cocco, A. Sotgiu, G. Costa, M.R. Murru, C. Mancosu, and R. Murru HLA-DR, DQ and APOE genotypes and gender influence in Sardinian primary progressive MS Neurology 64 2005 564 566
32. M. Pinholt, J.L. Frederiksen, P.S. Andersen, and M. Christiansen Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis Mult Scler 11 2005 511 515
33. G.S. Ramsaransing, D.J. Heersema, and J. De Keyser Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis Eur J Neurol 12 2005 514 518
34. G. Koutsis, M. Panas, G. Karadima, D. Mandellos, C. Sfagos, and C. Potagas APOE genotypes in Greek multiple sclerosis patients: no effect on the MS Severity Score J Neurol 254 2007 394 395
35. K.S. Lee, Y. Jang, Y.K. Chung, J.H. Chung, B.H. Oh, and C.H. Hong Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly Arch Gerontol Geriatr 50 2010 69 72
36. S.J. Weatherby, C.L. Mann, M.B. Davies, D. Carthy, A.A. Fryer, and M.D. Boggild Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis Mult Scler 6 2000 32 36
37. B. Zakrzewska-Pniewska, M. Styczynska, A. Podlecka, R. Samocka, B. Peplonska, and M. Barcikowska Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis Mult Scler 10 2004 266 271
38. J.N. Zwemmer, T. van Veen, L. van Winsen, G.J. van Kamp, F. Barkhof, and C.H. Polman No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis Mult Scler 10 2004 272 277
39. O.E. Mustafina, K.Z. Bakhtiiarova, A.M. Mikhailova, I.A. Tuktarova, A.N. Khusainova, and T.R. Nasibullin Analysis of the association of allelic variants of apolypoprotein E and interleukin 1 beta genes with multiple sclerosis in ethnic Tatars Genetika 44 2008 407 413
40. A. Bonetti, K. Koivisto, T. Pirttila, I. Elovaara, M. Reunanen, and M. Laaksonen A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility J Neuroimmunol 208 2009 119 124
41. O. Gaillard, A. Gervais, D. Meillet, E. Plassart, B. Fontaine, and O. Lyon-Caen Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation J Neurol Sci 158 1998 180 186
42. D.C. Rubinsztein, C.S. Hanlon, R.M. Irving, S. Goodburn, D.G. Evans, and H. Kellar-Wood Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease Mol Cell Probes 8 1994 519 525
43. C. Enzinger, S. Ropele, S. Strasser-Fuchs, P. Kapeller, H. Schmidt, and B. Poltrum Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele Arch Neurol 60 2003 65 70
44. C. Carlin, L. Murray, D. Graham, D. Doyle, and J. Nicoll Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele J Neuropathol Exp Neurol 59 2000 361 367
45. T. Pirttila, M. Haanpaa, P.D. Mehta, and T. Lehtimaki Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster Acta Neurol Scand 102 2000 94 98
46. A. Gervais, O. Gaillard, E. Plassart, J. Reboul, B. Fontaine, and E. Schuller Apolipoprotein E polymorphism in multiple sclerosis Ann Clin Biochem 35 Pt 1 1998 135 136
47. G. Koutsis, M. Panas, E. Giogkaraki, C. Potagas, G. Karadima, and C. Sfagos APOE epsilon4 is associated with impaired verbal learning in patients with MS Neurology 68 2007 546 549
48. R.L. Oliveri, R. Cittadella, G. Sibilia, I. Manna, P. Valentino, and A. Gambardella APOE and risk of cognitive impairment in multiple sclerosis Acta Neurol Scand 100 1999 290 295
49. E. Losonczi, K. Bencsik, Z. Fricska Nagy, V. Honti, E. Szalczer, and C. Rajda APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis Swiss Med Wkly 140 2010 w13119 LID-10.4414/smw.2010.13119 [doi] LID-20.
50. W.J. Hader, M. Elliot, and G.C. Ebers Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada Neurology 38 1988 617 621
51. J.L. Haines, M. Ter-Minassian, A. Bazyk, J.F. Gusella, D.J. Kim, and H. Terwedow A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group Nat Genet 13 1996 469 471
52. G.C. Ebers, K. Kukay, D.E. Bulman, A.D. Sadovnick, G. Rice, and C. Anderson A full genome search in multiple sclerosis Nat Genet 13 1996 472 476
53. S. Sawcer, H.B. Jones, R. Feakes, J. Gray, N. Smaldon, and J. Chataway A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 Nat Genet 13 1996 464 468
54. S. Kuokkanen, M. Gschwend, J.D. Rioux, M.J. Daly, J.D. Terwilliger, and P.J. Tienari Genomewide scan of multiple sclerosis in Finnish multiplex families Am J Hum Genet 61 1997 1379 1387
55. L.H. Wise, J.S. Lanchbury, and C.M. Lewis Meta-analysis of genome searches Ann Hum Genet 63 1999 263 272
56. S.C. Rall Jr., K.H. Weisgraber, and R.W. Mahley Jr. Human apolipoprotein E. The complete amino acid sequence J Biol Chem 257 1982 4171 4178
57. G. Bu Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nat Rev Neurosci 10 2009 333 344
58. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
59. N.A. Elshourbagy, W.S. Liao, R.W. Mahley, and J.M. Taylor Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets Proc Natl Acad Sci U S A 82 1985 203 207
60. L. Bertram, and R.E. Tanzi Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat Rev Neurosci 9 2008 768 778
61. T.D. Burt, B.K. Agan, V.C. Marconi, W. He, H. Kulkarni, and J.E. Mold Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression Proc Natl Acad Sci U S A 105 2008 8718 8723
62. M. Martinez, A. Brice, J.R. Vaughan, A. Zimprich, M.M. Breteler, and G. Meco Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease Am J Med Genet B Neuropsychiatr Genet 136B 2005 72 74
63. R.M. Burwick, P.P. Ramsay, J.L. Haines, S.L. Hauser, J.R. Oksenberg, and M.A. Pericak-Vance APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers Neurology 66 2006 1373 1383